✦ LIBER ✦

A phase II study of combined administration of dacarbazine and carboplatin with home therapy of recombinant interleukin-2 and interferon-α2a in patients with advanced malignant melanoma

✍ Scribed by Han G. Ron; Yair Mordish; Avi Eisenthal; Yehuda Skornick; Moshe J. Inbar; Samario Chaitchik

Publisher: Springer-Verlag
Year: 1994
Tongue: English
Weight: 584 KB
Volume: 38
Category: Article
ISSN: 0340-7004
DOI: 10.1007/bf01517207

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Combined treatment with pegylated interf

Combined treatment with pegylated interferon–α-2a and dacarbazine in patients with advanced metastatic melanoma : A phase 2 study

✍ Axel Hauschild; Reinhard Dummer; Selma Ugurel; Katharina C. Kaehler; Friederike 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 105 KB

A phase I-II study of dacarbazine in com

A phase I-II study of dacarbazine in combination with outpatient interleukin-2 in metastatic malignant melanoma

✍ Lawrence E. Flaherty; Bruce G. Redman; Guy G. Chabot; Silvana Martino; Steven M. 📂 Article 📅 1990 🏛 John Wiley and Sons 🌐 English ⚖ 699 KB

A phase II study of dacarbazine and cisp

A phase II study of dacarbazine and cisplatin in combination with outpatient administered interleukin-2 in metastatic malignant melanoma

✍ Lawrence E. Flaherty; Bruce G. Redman; Silvana Martino; Michael Kraut; Manuel Va 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 588 KB

Recombinant interferon α-2a in combinati

Recombinant interferon α-2a in combination with dacarbazine in the treatment of metastatic malignant melanoma: analysis of long-term responding patients

✍ Ilan G. Ron; Moshe J. Inbar; Mordechai Gutman; Ofer Merimsky; Samario Chaitchik 📂 Article 📅 1993 🏛 Springer-Verlag 🌐 English ⚖ 987 KB

Cisplatin, dacarbazine, and fotemustine

Cisplatin, dacarbazine, and fotemustine plus interferon α in patients with advanced malignant melanoma : A multicenter Phase II study of the Southern Italy Cooperative Oncology Group

✍ Antonio Daponte; Paolo A. Ascierto; Adriano Gravina; Maria Teresa Melucci; Giuse 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 90 KB 👁 1 views

A phase I study of recombinant human int

A phase I study of recombinant human interleukin-2 and alpha-interferon-2a in patients with renal cell cancer, colorectal cancer, and malignant melanoma

✍ A. Mittelman; M. Huberman; C. Puccio; B. Fallon; J. Tessitore; S. Savona; R. Eyr 📂 Article 📅 1990 🏛 John Wiley and Sons 🌐 English ⚖ 662 KB

Preclinical data suggest synergy of interleukin-2 (IL-2) combined with alphainterferon (IFN). In addition, toxicities of IL-2 may be decreased by intermittent continuous infusion. The purpose of this trial was to determine the maximum tolerated dose (MTD) of recombinant IL-2 combined with alpha-IFN